Cancer Biology and Therapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 5.7 | Q1 | 78.7% | 1.407 | Q1 | 91.0% |
| 2024 | 4.6 | Q1 | 75.5% | 1.202 | Q1 | 88.5% |
| 2023 | 4.4 | Q2 | 70.6% | 0.914 | Q2 | 83.3% |
| 2022 | 3.6 | Q2 | 54.5% | 0.996 | Q1 | 86.2% |
| 2021 | 4.9 | Q2 | 65.5% | 0.888 | Q2 | 83.9% |
| 2020 | — | — | 1.166 | Q1 | 88.4% | |
| 2019 | — | — | 1.116 | Q1 | 88.0% | |
| 2018 | — | — | 1.240 | Q1 | 88.5% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1555-8576
ISSN
1538-4047
country
UScoverage
2002-2026